Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
COSMOS Pharmaceutical Corporation ( (JP:3349) ) has shared an update.
COSMOS Pharmaceutical Corporation is considering lowering its investment unit to enhance stock market vitality by expanding its investor base and improving stock liquidity. The decision will be based on a comprehensive analysis of financial performance, stock price trends, shareholder composition, and other relevant factors.
The most recent analyst rating on (JP:3349) stock is a Buy with a Yen11500.00 price target. To see the full list of analyst forecasts on COSMOS Pharmaceutical Corporation stock, see the JP:3349 Stock Forecast page.
More about COSMOS Pharmaceutical Corporation
COSMOS Pharmaceutical Corporation operates in the pharmaceutical industry, focusing on the production and distribution of pharmaceutical products. The company is listed on the Tokyo Stock Exchange Prime Market and is committed to expanding its investor base and improving stock liquidity.
Average Trading Volume: 329,941
Technical Sentiment Signal: Buy
Current Market Cap: Yen734.7B
For a thorough assessment of 3349 stock, go to TipRanks’ Stock Analysis page.